|
000
| 01615nam 2200373zi 4500 |
|---|
| 001 | 9.886144 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107171333 |
|---|
| 006 | m o d f |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 200422t20202020onc ob f00| 0 eng d |
|---|
| 020 | |a9780660347059 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH139-15/2020E-PDF |
|---|
| 245 | 00|aGood manufacturing practices guide for drug products. |
|---|
| 264 | 1|a[Ottawa] : |bHealth Canada = Santé Canada, |c2020. |
|---|
| 264 | 4|c©2020 |
|---|
| 300 | |a1 online resource (159 pages) |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: Lignes directrices sur les bonnes pratiques de fabrication des drogues. |
|---|
| 500 | |aIssued also in HTML format. |
|---|
| 500 | |a"GUI-0001." |
|---|
| 500 | |a"July 1, 2020." |
|---|
| 500 | |a"Replaces: Good manufacturing practices guide for drug products (GUI-0001) (February 28, 2018)." |
|---|
| 504 | |aIncludes bibliographical references (pages 152-159). |
|---|
| 650 | 0|aDrug factories|zCanada. |
|---|
| 710 | 1 |aCanada. |bHealth Canada, |eissuing body. |
|---|
| 775 | 08|tLignes directrices sur les bonnes pratiques de fabrication des drogues.|w(CaOODSP)9.886147 |
|---|
| 856 | 40|qPDF|s2.36 MB|uhttps://publications.gc.ca/collections/collection_2020/sc-hc/H139-15-2020-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-manufacturing-practices/guidance-documents/gmp-guidelines-0001/document.html |
|---|